Literature DB >> 11123248

Role of EP(2) and EP(3) PGE(2) receptors in control of murine renal hemodynamics.

L P Audoly1, X Ruan, V A Wagner, J L Goulet, S L Tilley, B H Koller, T M Coffman, W J Arendshorst.   

Abstract

The kidney plays a central role in long-term regulation of arterial blood pressure and salt and water homeostasis. This is achieved in part by the local actions of paracrine and autacoid mediators such as the arachidonic acid-prostanoid system. The present study tested the role of specific PGE(2) E-prostanoid (EP) receptors in the regulation of renal hemodynamics and vascular reactivity to PGE(2). Specifically, we determined the extent to which the EP(2) and EP(3) receptor subtypes mediate the actions of PGE(2) on renal vascular tone. Renal blood flow (RBF) was measured by ultrasonic flowmetry, whereas vasoactive agents were injected directly into the renal artery of male mice. Studies were performed on two independent mouse lines lacking either EP(2) or EP(3) (-/-) receptors and the results were compared with wild-type controls (+/+). Our results do not support a unique role of the EP(2) receptor in regulating overall renal hemodynamics. Baseline renal hemodynamics in EP(2)-/- mice [RBF EP(2)-/-: 5.3 +/- 0.8 ml. min(-1). 100 g kidney wt(-1); renal vascular resistance (RVR) 19.7 +/- 3.6 mmHg. ml(-1). min. g kidney wt] did not differ statistically from control mice (RBF +/+: 4.0 +/- 0.5 ml. min(-1). 100 g kidney wt(-1); RVR +/+: 25.4 +/- 4.9 mmHg. ml(-1). min. 100 g kidney wt(-1)). This was also the case for the peak RBF increase after local PGE(2) (500 ng) injection into the renal artery (EP(2)-/-: 116 +/- 4 vs. +/+: 112 +/- 2% baseline RBF). In contrast, we found that the absence of EP(3) receptors in EP(3)-/- mice caused a significant increase (43%) in basal RBF (7.9 +/- 0.8 ml. min(-1). g kidney wt(-1), P < 0.05 vs. +/+) and a significant decrease (41%) in resting RVR (11.6 +/- 1.4 mmHg. ml(-1). min. g kidney wt(-1), P < 0.05 vs. +/+). Local administration of 500 ng of PGE(2) into the renal artery caused more pronounced renal vasodilation in EP(3)-/- mice (128 +/- 2% of basal RBF, P < 0.05 vs. +/+). We conclude that EP(3 )receptors mediate vasoconstriction in the kidney of male mice and its actions are tonically active in the basal state. Furthermore, EP(3) receptors are capable of buffering PGE(2)-mediated renal vasodilation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11123248     DOI: 10.1152/ajpheart.2001.280.1.H327

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  13 in total

Review 1.  The choreography of cyclooxygenases in the kidney.

Authors:  G A FitzGerald
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 2.  Prostaglandin E2 modulation of blood pressure homeostasis: studies in rodent models.

Authors:  Christina E Swan; Richard M Breyer
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-07-27       Impact factor: 3.072

Review 3.  Distinct roles of central and peripheral prostaglandin E2 and EP subtypes in blood pressure regulation.

Authors:  Tianxin Yang; Yaomin Du
Journal:  Am J Hypertens       Date:  2012-06-14       Impact factor: 2.689

4.  EP1 disruption attenuates end-organ damage in a mouse model of hypertension.

Authors:  Christina S Bartlett; Kelli L Boyd; Raymond C Harris; Roy Zent; Richard M Breyer
Journal:  Hypertension       Date:  2012-09-24       Impact factor: 10.190

5.  Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.

Authors:  Zhonghua Qi; Chuan-Ming Hao; Robert I Langenbach; Richard M Breyer; Reyadh Redha; Jason D Morrow; Matthew D Breyer
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

6.  Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia.

Authors:  Sofiyan Saleem; Yun Tai Kim; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  J Neuroimmunol       Date:  2009-02-08       Impact factor: 3.478

7.  Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice.

Authors:  Soon Yew Tang; James Monslow; Leslie Todd; John Lawson; Ellen Puré; Garret A FitzGerald
Journal:  Circulation       Date:  2014-02-11       Impact factor: 29.690

8.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

9.  Dual modulation of urinary bladder activity and urine flow by prostanoid EP3 receptors in the conscious rat.

Authors:  M J Jugus; J P Jaworski; P B Patra; J Jin; D M Morrow; N J Laping; R M Edwards; K S Thorneloe
Journal:  Br J Pharmacol       Date:  2009-05-22       Impact factor: 8.739

10.  Non-steroid anti-inflammatory drugs, prostaglandins, and cancer.

Authors:  Viola Allaj; Changxiong Guo; Daotai Nie
Journal:  Cell Biosci       Date:  2013-02-06       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.